Natac Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 181

Employees

  • Stock Symbol
  • NAT

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.64
  • (As of Wednesday Closing)

Natac General Information

Description

Natac Natural Ingredients SA is engaged in producing sustainable natural ingredients from botanicals and fish. The company researches, develops, produces, and markets natural ingredients derived from plant extracts. The group has two operating segments: Vegetable extracts, and Omega-3, of which it derives maximum revenue from Vegetable Extracts.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Avenida Rita Levi Montalcini, 14
  • Getafe
  • 28906 Madrid
  • Spain
+34 918
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Other Healthcare Services
Stock Exchange
MAD
Corporate Office
  • Avenida Rita Levi Montalcini, 14
  • Getafe
  • 28906 Madrid
  • Spain
+34 918

Natac Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Natac Stock Performance

As of 18-Nov-2026, Natac’s stock price is $0.64. Its current market cap is $279M with 438M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.64 $0.64 $0.61 - $1.04 $279M 438M 18K

Natac Financials Summary

As of 31-Dec-2025, Natac has a trailing 12-month revenue of $53.9M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 508,808 508,808 386,226 339,901
Revenue 53,947 53,947 38,794 28,734
EBITDA 16,133 16,133 10,573 18,364
Net Income 1,207 1,207 430 6,940
Total Assets 165,383 165,383 140,802 141,575
Total Debt 99,202 99,202 83,371 78,582
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Natac Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Natac‘s full profile, request access.

Request a free trial

Natac Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Natac Natural Ingredients SA is engaged in producing sustainable natural ingredients from botanicals and fish. The compa
Biotechnology
Madrid, Spain
181 As of 2025

Barcelona, Spain
 

Milan, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Natac Competitors (3)

One of Natac’s 3 competitors is Euromed (Consumer Non-Durables), a Formerly PE-Backed company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Euromed (Consumer Non-Durables) Formerly PE-Backed Barcelona, Spain
Indena Corporation Milan, Italy
MartinBauer Corporation Vestenbergsgreuth, Germany
You’re viewing 3 of 3 competitors. Get the full list »

Natac Patents

Natac Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2829277-A1 Use of a-type proanthocyanidins in treating a mineralocorticoid receptor related disease Inactive 26-Jul-2013
CA-2915164-A1 Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof Inactive 13-Jun-2013
EP-2813221-A1 Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof Inactive 13-Jun-2013
EP-3007687-A1 Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof Active 13-Jun-2013
EP-3007687-B1 Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof Active 13-Jun-2013 A61K31/7034
To view Natac’s complete patent history, request access »

Natac Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Natac Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Natac‘s full profile, request access.

Request a free trial

Natac Investments & Acquisitions (3)

Natac’s most recent deal was a Merger/Acquisition with IFFE Futura for . The deal was made on 06-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
IFFE Futura 06-Nov-2023 Merger/Acquisition Other Pharmaceuticals and Biotechnology
INOreal 09-Jun-2022 Buyout/LBO Laboratory Services (Healthcare)
Natac Solutions 07-Nov-2018 Joint Venture Other Healthcare Services
To view Natac’s complete investments and acquisitions history, request access »

Natac ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Real Estate

Industry

Rank

Percentile

REITs

Subindustry

Rank

Percentile

To view Natac’s complete esg history, request access »

Natac Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
IFFE Futura Madrid, Spain 2011
INOreal Ploufragan, France 2008

Natac FAQs

  • When was Natac founded?

    Natac was founded in 2010.

  • Where is Natac headquartered?

    Natac is headquartered in Madrid, Spain.

  • What is the size of Natac?

    Natac has 181 total employees.

  • What industry is Natac in?

    Natac’s primary industry is Biotechnology.

  • Is Natac a private or public company?

    Natac is a Public company.

  • What is Natac’s stock symbol?

    The ticker symbol for Natac is NAT.

  • What is the current stock price of Natac?

    As of 18-Nov-2026 the stock price of Natac is $0.64.

  • What is the current market cap of Natac?

    The current market capitalization of Natac is $279M.

  • What is Natac’s current revenue?

    The trailing twelve month revenue for Natac is $53.9M.

  • Who are Natac’s competitors?

    Euromed (Consumer Non-Durables), Indena, and MartinBauer are competitors of Natac.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process